Skip to main content
. Author manuscript; available in PMC: 2022 Dec 23.
Published in final edited form as: J Med Chem. 2021 Dec 2;64(24):18054–18081. doi: 10.1021/acs.jmedchem.1c01476

Figure 7.

Figure 7.

Effects of GSK690693-based AKT degraders on degrading AKT and inhibiting downstream signaling. PC3 cells were treated with GSK690693 or indicated compounds at 1 μM for 24 h. The cell lysates were analyzed by western blotting to examine the protein levels of T-AKT, P-AKT (S473), P-PRAS40 (T246), and P-S6 (S240/244). β-Actin was used as the loading control.